Hepatitis B recurrence mystery found, recovery is no longer difficult

High-throughput virus gene DNA detection and virus mutation (drug resistance) biochip detection, combined with the latest antiviral treatment is expected to solve the problem of hepatitis B recurrence

In recent years, the issue of liver disease recurrence has received widespread attention. Many patients complain that the condition cannot be cured repeatedly. Many people have lost confidence in the treatment after a long period of treatment, thinking that hepatitis B cannot be cured at all. Is liver disease really so difficult to treat? Why does the disease always come and go?

I met many patients in the outpatient clinic, relying on high-priced imported medicines and ancestral secret recipes , specific drugs, but it is often difficult to obtain the desired curative effect, so the psychological burden is too heavy, and even a small number of patients think that hepatitis B has no cure and give up treatment.

Clinical studies have found that inappropriate treatment and incomplete virus clearance are the main reasons for the recurrence of hepatitis B . In the past, treatment was based on hepatitis B two-and-a-half and liver function tests, lacking in-depth and detailed analysis of the condition of hepatitis B patients, hastily prescribed medication for thousands of people, ignoring individual differences in patients, and blindness in treatment. If patients use drugs improperly, such as unequal doses, the drugs will be inappropriate due to individual differences, resulting in treatment failure. Many patients did not pay enough attention to this, and took a detour in the treatment of hepatitis B, so the disease recurred and could not be cured for a long time.

Even if you choose a suitable drug, the virus does not mean that it can be completely removed. The molecular weight of modern drugs is relatively large. Due to technical bottlenecks, traditional hepatitis B treatment methods cannot break through the dense nucleus and deliver the drug directly to the lesion. No matter how strong the antiviral drug is, it can only inhibit the virus in the blood and cytoplasm. There is no way for the ccc-DNA replication template hidden in the nucleus, which gives the virus a chance to resurface. After a period of “expansion”, the remaining hepatitis B virus re-occupied the “highlands”, leading to the recurrence of the patient’s condition. For these patients, the complexity of the disease is relatively higher, the difficulty of treatment increases, and patients generally lack confidence in treatment, making clinical treatment more difficult.

In-depth understanding of the disease and accurate diagnosis are the keys to curing liver diseases. The standardized medication process for liver disease determines which type of antiviral drug the patient should take and the curative effect of the drug without determining the amount of the virus in the body, whether it replicates, whether it is contagious, and how contagious it is. how.

Through clinical application, it is found that high-throughput virus gene DNA detection and virus mutation (drug resistance) biochip detection can provide a comprehensive and in-depth understanding of the virus situation in patients , to grasp the details of the disease. Such as virus genotype, virus quantity and infectivity, whether the virus is mutated and resistant, whether it needs treatment, and which type of drug the patient is sensitive to, etc., these can be seen at a glance. On this basis, combined with the The comprehensive treatment of western medicine has brought hope for the clinical cure of hepatitis B. The most sensitive drugs of the virus are delivered directly to the focus of the lesion through new technology, and the nucleation treatment is carried out, which can quickly kill the hepatitis B virus without damaging normal liver cells.

p class=”pgc-img-caption”>

Through the standard treatment of the new antiviral comprehensive therapy, the vast majority of people can get very good treatment As a result, it has brought hope of recovery to hepatitis B patients who had repeated illnesses and had been cured for a long time. I am Cheng Jinming, a liver doctor. For more detailed information, please leave a message in the comment area.